Skip to main content

Table 3 Relationship between ESSDAI domain and PSL dosage

From: Utility of the EULAR Sjögren syndrome disease activity index in Japanese children: a retrospective multicenter cohort study

  All
(n = 31)
High/medium dose PSL group
(n = 12)
No/low dose PSL group (n = 19)
Number of ESSDAI domains scored as active
 0 1 0 (0%) 1 (100%)
 1 7 0 (0%) 7 (100%)
 2 10 3 (30.0%) 7 (70.0%)
  ≥ 3 13 9 (69.2%) 4 (30.8%)
Maximum level of activity achieved in any of the 12 ESSDAI domains
 No 1 0 (0%) 1 (100%)
 Low 8 0 (0%) 8 (100%)
 Moderate 19 9 (47.3%) 10 (52.6%)
 High 3 3 (100%) 0 (0%)
  1. Abbreviations: ESSDAI EULAR Sjögren Syndrome Disease Activity Index, EULAR European League Against Rheumatism, PSL prednisolone
  2. Glucocorticoid dosages were graded as high (prednisolone (PSL) ≥ 0.5 mg/kg/day or equivalent), medium (PSL ≥0.2 but < 0.5 mg/kg/day or equivalent) and low (PSL < 0.2 mg/kg/day or equivalent)
  3. One patient did not have any active domains